Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Rating of “Moderate Buy” from Brokerages
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average […]
